SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-09-001586
Filing Date
2009-05-11
Accepted
2009-05-11 16:44:32
Documents
13
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q w73981e10vq.htm 10-Q 325399
2 EXHIBIT 10.1 w73981exv10w1.htm EX-10.1 94819
3 EXHIBIT 10.2 w73981exv10w2.htm EX-10.2 51388
4 EXHIBIT 10.3 w73981exv10w3.htm EX-10.3 223787
5 EXHIBIT 10.4 w73981exv10w4.htm EX-10.4 49905
6 EXHIBIT 10.5 w73981exv10w5.htm EX-10.5 78216
7 EXHIBIT 10.6 w73981exv10w6.htm EX-10.6 57432
8 EXHIBIT 10.07 w73981exv10w7.htm EX-10.7 90467
9 EXHIBIT 10.8 w73981exv10w8.htm EX-10.8 135867
10 EXHIBIT 31.1 w73981exv31w1.htm EX-31.1 7931
11 EXHIBIT 31.2 w73981exv31w2.htm EX-31.2 7978
12 EXHIBIT 32.1 w73981exv32w1.htm EX-32.1 2838
13 EXHIBIT 32.2 w73981exv32w2.htm EX-32.2 2915
  Complete submission text file 0000950133-09-001586.txt   1130348
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 09815675
SIC: 2836 Biological Products, (No Diagnostic Substances)